About Careers MedBlog Contact us

Developing Countries Threatened With Increasing Synthetic Drug Use: UN

by Rathi Manohar on June 24, 2010 at 12:25 PM
Font : A-A+

Developing Countries Threatened With Increasing Synthetic Drug Use: UN

With an increase in synthetic drug use, the UN has warned of the threat this poses to the developing world.

"The world's supply of the two main problem drugs -- opiates and cocaine -- keeps declining," the United Nations Office on Drugs and Crime (UNODC) found in its 2010 World Drug Report presented Wednesday.


In the last two years, the land used for opium cultivation worldwide has shrunk by 23 percent, it noted, while coca cultivation, most of it in the Andes and vital for cocaine and heroin production, has dropped by 28 percent in the last decade.

On the flip-side however, the global number of users of amphetamine-type stimulants (ATS) -- between 30 and 40 million -- was soon expected to top the combined number of opiate and cocaine users, the UNODC warned.

"We will not solve the world drugs problem if we simply push addiction from cocaine and heroin to other addictive substances and there are unlimited amounts of them, produced in mafia labs at trivial costs," director Antonio Maria Costa said.

With short trafficking routes -- ATS are often produced close to their target market -- and with raw materials readily and legally available, these drugs were harder to seize, the office noted.

While cocaine consumption has fallen significantly in the United States, the number of users in Europe has doubled in the last decade to 4.1 million in 2008, shifting trafficking routes with disastrous consequences for regional security and drug use in developing countries, the UNODC also said.

Summarising the problem, Costa pointed out: "People snorting coke in Europe are killing the pristine forests of the Andean countries and corrupting governments in West Africa."

Developing countries were increasingly falling prey to drugs, the office noted: heroin consumption was up in eastern Africa, cocaine use had increased in West Africa and South America, and production of synthetic drugs was also rising in Southeast Asia and the Middle East.

"We will not solve the world drugs problem by shifting consumption from the developed to the developing world," Costa concluded.

While users in rich countries had the necessary facilities to help them overcome their addiction, this was not the case for poorer nations, the UNODC chief said, calling for universal access to drug treatment.

In 2008, the last year for which data was available, only a fifth of drug addicts had access to treatment, leaving some 20 million users worldwide without care, the report said.

Drug addiction should be handled as a health issue, rather than an offence punishable by jail time, or even execution, it added.

"Just because people take drugs, or are behind bars, this doesn?t abolish their rights."

"I appeal to countries where people are executed for drug-related offences or, worse, are gunned down by extra-judicial hit squads, to end this practice," Costa urged.

Cannabis meanwhile remained the most widely produced and consumed drug, being grown in almost every country and smoked by between 130 and 190 million people every year, the UNODC found.

Source: AFP


Recommended Reading

Latest Drug News

 Parkinson's Unmet Needs Creates Path for New Entrants into the Market
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
 Ivosidenib Approved for Acute Myeloid Leukemia & Advanced Cholangiocarcinoma
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
Sacubitril/valsartan Unleashes Hope for Heart Failure Patients
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Developing Countries Threatened With Increasing Synthetic Drug Use: UN Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests